IDEAL DOSE OF ACETYLSALICYLIC ACID FOR CARDIAC PATIENTS: THE SEARCH IS OVER?

IDEAL DOSE OF ACETYLSALICYLIC ACID FOR CARDIAC PATIENTS: THE SEARCH IS OVER?

.

Bibliographic Details
Main Author:	O. V. Averkov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2011-08-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1134

Similar Items

ACETYLSALICYLIC ACID AND PREVENTION OF FATAL OUTCOMES IN CARDIOVASCULAR DISEASE: SELECTING MEDICATION FORM AND DOSE
by: O. V. Averkov
Published: (2012-08-01)

Acetylsalicylic acid as an anti-platelet agent: what forms should be used, according to evidence-based medicine?
by: O. V. Averkov
Published: (2010-04-01)

Early discontinuation of dual antiplatelet therapy via acetylsalicylic acid cessation in patients with acute coronary syndrome undergoing percutaneous coronary interventions to reduce the bleeding risk
by: O. V. Averkov
Published: (2021-02-01)

Cost-minimization analysis of application acetylsalicylic acid in cardiac elderly patients
by: D. Yu. Belousov, et al.
Published: (2018-05-01)

Assessment of efficacy of single dose acetylsalicylic acid over a 24-hour period
by: Reşat Mehmet Baha, et al.
Published: (2015-07-01)

The Impact of Moderate-Dose Acetylsalicylic Acid in the Reduction of Inflammatory Cytokine and Prevention of Complication in Acute Phase of Kawasaki Disease: The Benefit of Moderate-Dose Acetylsalicylic Acid
by: Jung Eun Kwon, et al.
Published: (2020-10-01)

ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS
by: N. A. Dmitrieva, et al.
Published: (2016-01-01)

ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS
by: N. A. Dmitrieva, et al.
Published: (2016-01-01)

COMBINED ACETYLSALICYLIC ACID TABLETS TECHNOLOGY
by: A. V. Simonyan, et al.
Published: (2019-01-01)

THE POSSIBILITIES OF USING A NEW FIXED-DOSE COMBINATION OF ROSUVASTATIN AND ACETYLSALICYLIC ACID: FOCUS GROUPS OF PATIENTS
by: O. D. Ostroumova, et al.
Published: (2018-07-01)

The Effect of Low Doses of Acetylsalicylic Acid on the Occurrence of Rectal Aberrant Crypt Foci
by: Marek Kowalczyk, et al.
Published: (2022-11-01)

ON THE 125TH ANNIVERSARY OF ACETYLSALICYLIC ACID
by: I. N. Bokarev, et al.
Published: (2016-01-01)

ACETYLSALICYLIC ACID IN THE PREVENTION OF ATHEROTHROMBOTIC EVENTS
by: A. V. Govorin, et al.
Published: (2015-12-01)

ACETYLSALICYLIC ACID IN THE PREVENTION OF ATHEROTHROMBOTIC EVENTS
by: A. V. Govorin, et al.
Published: (2015-12-01)

Acetylsalicylic acid in primary prevention among patients with arterial hypertension
by: A. V. Melekhov, et al.
Published: (2013-10-01)

Acetylsalicylic acid in the prevention and treatment of ischemic stroke
by: A. V. Fonyakin
Published: (2010-06-01)

ACETYLSALICYLIC ACID IN RHEUMATOLOGY: NEW EVIDENCE
by: Yuri Vladimirovich Muravyev, et al.
Published: (2013-12-01)

RESISTANCE TO ACETYLSALICYLIC ACID AND PREVALENCE OF THROMBOSIS IN PATIENTS WITH STABLE ANGINA
by: N. F. Putchinyan, et al.
Published: (2015-12-01)

RESISTANCE TO ACETYLSALICYLIC ACID AND PREVALENCE OF THROMBOSIS IN PATIENTS WITH STABLE ANGINA
by: N. F. Putchinyan, et al.
Published: (2015-12-01)

ACETYLSALICYLIC ACID: WHAT'S NEW IN THE OLD DRUG?
by: I. V. Zhirov
Published: (2015-12-01)

ACETYLSALICYLIC ACID: WHAT'S NEW IN THE OLD DRUG?
by: I. V. Zhirov
Published: (2015-12-01)

ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES
by: E. N. Dankovtseva
Published: (2015-09-01)

ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES
by: E. N. Dankovtseva
Published: (2015-09-01)

Acetylsalicylic acid as an adjuvant therapy for schizophrenia
by: Grobbee Diederick E, et al.
Published: (2006-10-01)

Influence of acetylsalicylic acid on hematotoxicity of benzene
by: Joanna Kowalówka-Zawieja, et al.
Published: (2013-10-01)

Efficacy of Low Doses of Acetylsalicylic Acid in the Prevention of Preeclampsia in Women with Type 1 and 2 Diabetes Mellitus
by: Roman V. Kapustin, et al.
Published: (2021-10-01)

LOW DOSAGE ACETYLSALICYLIC ACID: A VARIETY OF FORMULATIONS
by: V. V. Rafalsky, et al.
Published: (2017-08-01)

Clinical pharmacology of acetylsalicylic acid as an anti-thrombotic agent
by: V. V. Rafalsky, et al.
Published: (1970-01-01)

Platelet Inhibition by Low-Dose Acetylsalicylic Acid Reduces Neuroinflammation in an Animal Model of Multiple Sclerosis
by: Anna Vogelsang, et al.
Published: (2021-09-01)

ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF STROKE
by: P. S. Laguta
Published: (2017-05-01)

Acetylsalicylic Acid–Primus Inter Pares in Pharmacology
by: Łukasz Fijałkowski, et al.
Published: (2022-12-01)

The Influence of UV Light on Photodegradation of Acetylsalicylic Acid
by: Monica Daescu, et al.
Published: (2021-04-01)

Study of pharmaceutical properties of low-dosage enteric-coated acetylsalicylic acid
by: V. V. Rafalsky, et al.
Published: (2016-02-01)

Compliance as the major effectiveness determinant in preventive acetylsalicylic acid therapy
by: V. V. Rafalskiy, et al.
Published: (2011-04-01)

CREATING A PROLONGED FORM OF ACETYLSALICYLIC ACID: AN EXPERIMENTAL APPROACH
by: V. I. Sevastianov, et al.
Published: (2016-04-01)

Low-Dose Acetylsalicylic Acid and Mitochondria-Targeted Antioxidant Mitoquinone Attenuate Non-Alcoholic Steatohepatitis in Mice
by: Saadet Turkseven, et al.
Published: (2023-04-01)

Effects of different acetylsalicylic acid doses on body organs, histopathology, and serum biochemical parameters in broiler birds
by: Muhammad Muneeb, et al.
Published: (2022-07-01)

Intermolecular interactions of decamethoxinum and acetylsalicylic acid in systems of various complexity levels
by: O. V. Vashchenko, et al.
Published: (2016-07-01)

Analysis of Pharmacokinetic Parameters of Acetylsalicylic Acid for Prediction of Potential Nephrotoxic Effects
by: L. M. Krasnykh, et al.
Published: (2021-12-01)

Acetylsalicylic acid resistance: relevance of correct dosage form
by: N. M. Vorobyova
Published: (2013-12-01)